Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine model.

Source:http://linkedlifedata.com/resource/pubmed/id/17726606

Download in:

View as

General Info

PMID
17726606